NCT06599333

Brief Summary

In the Middle East, particularly Lebanon, the adoption of digital health interventions has been growing. Mobile health (mHealth) platforms, social media campaigns, and telemedicine services are being integrated into healthcare systems. However, while digital marketing for health promotion is gaining traction globally, few studies have specifically examined its impact on medication adherence in Lebanon. The e-MedAL Study aims to fill this gap by evaluating whether tailored digital marketing strategies can foster better adherence among patients with chronic diseases, taking into account the local healthcare infrastructure and cultural context. Lebanon faces unique challenges in managing chronic diseases due to its healthcare system, which is fragmented and highly privatized. The ongoing economic crisis, coupled with the COVID-19 pandemic, has placed additional stress on healthcare delivery, making it difficult for patients to maintain consistent access to medications. Moreover, the high cost of chronic medications, coupled with the population\'s general reliance on out-of-pocket expenditures, contributes to non-adherence. Exploring cost-effective and scalable interventions like digital marketing becomes vital in this context. Lebanon has a high internet and mobile phone penetration rate, which presents an opportunity for leveraging digital tools to promote health. By utilizing culturally tailored messaging and communication strategies, the e-MedAL Study has the potential to improve medication adherence rates significantly. This, in turn, would alleviate the burden on healthcare resources, enhance patient outcomes, and reduce the economic impact of poorly managed chronic diseases in the country. Furthermore, the success of this initiative could serve as a model for other countries in the region facing similar healthcare challenges. Lebanon's diverse and tech-savvy population makes it an ideal test case for assessing the role of digital marketing in healthcare, particularly in resource-constrained settings.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
192

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 15, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 11, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2024

Completed
Last Updated

March 4, 2025

Status Verified

March 1, 2025

Enrollment Period

4 months

First QC Date

September 11, 2024

Last Update Submit

March 3, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Effectiveness of digital marketing strategies

    Correlation between the score of the schemes, in addition to some inter-item correlation assessment, as mentioned earlier, and the participants general characteristics.

    through study completion, an average of 3 months

Study Arms (1)

Patients

Patients coming to community pharmacies and taking at least the same medication for 6 months

Behavioral: Adherence to Care

Interventions

Questionnaire to assess the perception and readiness of patients in Lebanon towards the effectiveness of digital marketing strategies to improve their adherence to medications they take chronically The following sections will be considered: * General Characteristics of the Participants * Medical and medication history * Assessment of adherence to chronic medications (Likert scale) * Digital Marketing Strategies to improve adherence to chronic medications (Likert scale) * Perceived barriers to adopting digital marketing strategies in Lebanon (Likert scale)

Patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients from the general population residing in Lebanon and taking the same medication for at least six consecutive months

You may qualify if:

  • Patients taking the same medication for at least six months
  • Lebanese patients
  • Those who agree to participate in the study

You may not qualify if:

  • Those with electronic illiteracy
  • Those who are not themselves responsible for purchasing the medications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lebanese University

Beirut, 0000, Lebanon

Location

Study Officials

  • Georges Hatem

    Lebanese University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Clinical and Epidemiological Professor

Study Record Dates

First Submitted

September 11, 2024

First Posted

September 19, 2024

Study Start

July 15, 2024

Primary Completion

November 15, 2024

Study Completion

December 30, 2024

Last Updated

March 4, 2025

Record last verified: 2025-03

Locations